For research use only. Not for therapeutic Use.
Canagliflozin hemihydrate,(CAT: I005475) is a medication used for the management of type 2 diabetes mellitus. It belongs to the class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. Canagliflozin works by inhibiting the SGLT2 protein in the kidneys, which reduces the reabsorption of glucose and increases urinary glucose excretion. This mechanism helps lower blood glucose levels in individuals with diabetes.
Catalog Number | I005475 |
CAS Number | 928672-86-0 |
Synonyms | JNJ 28431754; JNJ-28431754; JNJ28431754; TA 7284; TA-7284; TA7284; JNJ-24831754-ZAE; JNJ-28431754-AAA; Canagliflozin hemihydrate; brand name: Invokana. Sulisent.;(3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxy |
Molecular Formula | C48H52F2O11S2 |
Purity | 98% |
Target | SGLT-2 inhibitor |
Solubility | Soluble in DMSO |
Appearance | Solid Powder |
Storage | 0 - 4°C for short term ,or -20 °C for long term |
Analysis method | HPLC |
IUPAC Name | (2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol;hydrate |
InChI | InChI=1S/2C24H25FO5S.H2O/c2*1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14;/h2*2-10,19,21-24,26-29H,11-12H2,1H3;1H2/t2*19-,21-,22+,23-,24+;/m11./s1 |
InChIKey | VHOFTEAWFCUTOS-TUGBYPPCSA-N |
SMILES | CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F.CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F.O |
Reference | 1:Acta Crystallogr E Crystallogr Commun. 2016 Apr 26;72(Pt 5):734-6. doi: 10.1107/S2056989016006769. eCollection 2016 May 1. Crystal structure of canagliflozin hemihydrate.Liu KH,Gu JM,Hu XR,Tang GP, PMID: 27308030 PMCID: PMC4908520 DOI: 10.1107/S2056989016006769<br /> |